866-997-4948(US-Canada Toll Free)

Global Antibody-drug Conjugates Sales Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 101 Pages

In this report, the global Antibody-drug Conjugates market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of Antibody-drug Conjugates for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Antibody-drug Conjugates market competition by top manufacturers/players, with Antibody-drug Conjugates sales volume, Price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including
F. Hoffmann-La Roche
Seattle Genetics
Takeda Pharmaceuticals
AbbVie
AbGenomics
ADC Therapeutics
Agensys
ALMAC Group
Ambrx
Astellas Pharma
On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into
Seattle Genetics technology
ImmunoGen technology
Immunomedics technology
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antibody-drug Conjugates for each application, including
IgG1 antibodies
HER2 antibodies

Table of Contents

Global Antibody-drug Conjugates Sales Market Report 2017
1 Antibody-drug Conjugates Market Overview
1.1 Product Overview and Scope of Antibody-drug Conjugates
1.2 Classification of Antibody-drug Conjugates by Product Category
1.2.1 Global Antibody-drug Conjugates Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Antibody-drug Conjugates Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Seattle Genetics technology
1.2.4 ImmunoGen technology
1.2.5 Immunomedics technology
1.3 Global Antibody-drug Conjugates Market by Application/End Users
1.3.1 Global Antibody-drug Conjugates Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 IgG1 antibodies
1.3.3 HER2 antibodies
1.4 Global Antibody-drug Conjugates Market by Region
1.4.1 Global Antibody-drug Conjugates Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.3 China Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.4 Europe Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.5 Japan Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.6 Southeast Asia Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.7 India Antibody-drug Conjugates Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Antibody-drug Conjugates (2012-2022)
1.5.1 Global Antibody-drug Conjugates Sales and Growth Rate (2012-2022)
1.5.2 Global Antibody-drug Conjugates Revenue and Growth Rate (2012-2022)

2 Global Antibody-drug Conjugates Competition by Players/Suppliers, Type and Application
2.1 Global Antibody-drug Conjugates Market Competition by Players/Suppliers
2.1.1 Global Antibody-drug Conjugates Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Antibody-drug Conjugates Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Antibody-drug Conjugates (Volume and Value) by Type
2.2.1 Global Antibody-drug Conjugates Sales and Market Share by Type (2012-2017)
2.2.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2012-2017)
2.3 Global Antibody-drug Conjugates (Volume and Value) by Region
2.3.1 Global Antibody-drug Conjugates Sales and Market Share by Region (2012-2017)
2.3.2 Global Antibody-drug Conjugates Revenue and Market Share by Region (2012-2017)
2.4 Global Antibody-drug Conjugates (Volume) by Application

3 United States Antibody-drug Conjugates (Volume, Value and Sales Price)
3.1 United States Antibody-drug Conjugates Sales and Value (2012-2017)
3.1.1 United States Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
3.1.2 United States Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
3.1.3 United States Antibody-drug Conjugates Sales Price Trend (2012-2017)
3.2 United States Antibody-drug Conjugates Sales Volume and Market Share by Players
3.3 United States Antibody-drug Conjugates Sales Volume and Market Share by Type
3.4 United States Antibody-drug Conjugates Sales Volume and Market Share by Application

4 China Antibody-drug Conjugates (Volume, Value and Sales Price)
4.1 China Antibody-drug Conjugates Sales and Value (2012-2017)
4.1.1 China Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
4.1.2 China Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
4.1.3 China Antibody-drug Conjugates Sales Price Trend (2012-2017)
4.2 China Antibody-drug Conjugates Sales Volume and Market Share by Players
4.3 China Antibody-drug Conjugates Sales Volume and Market Share by Type
4.4 China Antibody-drug Conjugates Sales Volume and Market Share by Application

5 Europe Antibody-drug Conjugates (Volume, Value and Sales Price)
5.1 Europe Antibody-drug Conjugates Sales and Value (2012-2017)
5.1.1 Europe Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
5.1.2 Europe Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
5.1.3 Europe Antibody-drug Conjugates Sales Price Trend (2012-2017)
5.2 Europe Antibody-drug Conjugates Sales Volume and Market Share by Players
5.3 Europe Antibody-drug Conjugates Sales Volume and Market Share by Type
5.4 Europe Antibody-drug Conjugates Sales Volume and Market Share by Application

6 Japan Antibody-drug Conjugates (Volume, Value and Sales Price)
6.1 Japan Antibody-drug Conjugates Sales and Value (2012-2017)
6.1.1 Japan Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
6.1.2 Japan Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
6.1.3 Japan Antibody-drug Conjugates Sales Price Trend (2012-2017)
6.2 Japan Antibody-drug Conjugates Sales Volume and Market Share by Players
6.3 Japan Antibody-drug Conjugates Sales Volume and Market Share by Type
6.4 Japan Antibody-drug Conjugates Sales Volume and Market Share by Application

7 Southeast Asia Antibody-drug Conjugates (Volume, Value and Sales Price)
7.1 Southeast Asia Antibody-drug Conjugates Sales and Value (2012-2017)
7.1.1 Southeast Asia Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Antibody-drug Conjugates Sales Price Trend (2012-2017)
7.2 Southeast Asia Antibody-drug Conjugates Sales Volume and Market Share by Players
7.3 Southeast Asia Antibody-drug Conjugates Sales Volume and Market Share by Type
7.4 Southeast Asia Antibody-drug Conjugates Sales Volume and Market Share by Application

8 India Antibody-drug Conjugates (Volume, Value and Sales Price)
8.1 India Antibody-drug Conjugates Sales and Value (2012-2017)
8.1.1 India Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
8.1.2 India Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
8.1.3 India Antibody-drug Conjugates Sales Price Trend (2012-2017)
8.2 India Antibody-drug Conjugates Sales Volume and Market Share by Players
8.3 India Antibody-drug Conjugates Sales Volume and Market Share by Type
8.4 India Antibody-drug Conjugates Sales Volume and Market Share by Application

9 Global Antibody-drug Conjugates Players/Suppliers Profiles and Sales Data
9.1 F. Hoffmann-La Roche
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Antibody-drug Conjugates Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 F. Hoffmann-La Roche Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Seattle Genetics
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Antibody-drug Conjugates Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Takeda Pharmaceuticals
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Antibody-drug Conjugates Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Takeda Pharmaceuticals Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 AbbVie
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Antibody-drug Conjugates Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 AbbVie Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 AbGenomics
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Antibody-drug Conjugates Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 AbGenomics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 ADC Therapeutics
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Antibody-drug Conjugates Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 ADC Therapeutics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Agensys
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Antibody-drug Conjugates Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Agensys Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 ALMAC Group
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Antibody-drug Conjugates Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 ALMAC Group Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Ambrx
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Antibody-drug Conjugates Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Ambrx Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Astellas Pharma
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Antibody-drug Conjugates Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Astellas Pharma Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview

10 Antibody-drug Conjugates Maufacturing Cost Analysis
10.1 Antibody-drug Conjugates Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Antibody-drug Conjugates
10.3 Manufacturing Process Analysis of Antibody-drug Conjugates

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Antibody-drug Conjugates Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antibody-drug Conjugates Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Antibody-drug Conjugates Market Forecast (2017-2022)
14.1 Global Antibody-drug Conjugates Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Antibody-drug Conjugates Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Antibody-drug Conjugates Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Antibody-drug Conjugates Price and Trend Forecast (2017-2022)
14.2 Global Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Antibody-drug Conjugates Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Antibody-drug Conjugates Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Antibody-drug Conjugates Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Antibody-drug Conjugates Sales Forecast by Type (2017-2022)
14.3.2 Global Antibody-drug Conjugates Revenue Forecast by Type (2017-2022)
14.3.3 Global Antibody-drug Conjugates Price Forecast by Type (2017-2022)
14.4 Global Antibody-drug Conjugates Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Antibody-drug Conjugates
Figure Global Antibody-drug Conjugates Sales Volume Comparison (MT) by Type (2012-2022)
Figure Global Antibody-drug Conjugates Sales Volume Market Share by Type (Product Category) in 2016
Figure Seattle Genetics technology Product Picture
Figure ImmunoGen technology Product Picture
Figure Immunomedics technology Product Picture
Figure Global Antibody-drug Conjugates Sales Comparison (MT) by Application (2012-2022)
Figure Global Sales Market Share of Antibody-drug Conjugates by Application in 2016
Figure IgG1 antibodies Examples
Figure HER2 antibodies Examples
Figure Global Antibody-drug Conjugates Market Size (Million USD) by Regions (2012-2022)
Figure United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Antibody-drug Conjugates Sales Volume (MT) and Growth Rate (2012-2022)
Figure Global Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Antibody-drug Conjugates Sales Volume (MT) (2012-2017)
Table Global Antibody-drug Conjugates Sales (MT) of Key Players/Suppliers (2012-2017)
Table Global Antibody-drug Conjugates Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Antibody-drug Conjugates Sales Share by Players/Suppliers
Figure 2017 Antibody-drug Conjugates Sales Share by Players/Suppliers
Figure Global Antibody-drug Conjugates Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Antibody-drug Conjugates Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Antibody-drug Conjugates Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Antibody-drug Conjugates Revenue Share by Players
Table 2017 Global Antibody-drug Conjugates Revenue Share by Players
Table Global Antibody-drug Conjugates Sales (MT) and Market Share by Type (2012-2017)
Table Global Antibody-drug Conjugates Sales Share (MT) by Type (2012-2017)
Figure Sales Market Share of Antibody-drug Conjugates by Type (2012-2017)
Figure Global Antibody-drug Conjugates Sales Growth Rate by Type (2012-2017)
Table Global Antibody-drug Conjugates Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Antibody-drug Conjugates Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibody-drug Conjugates by Type (2012-2017)
Figure Global Antibody-drug Conjugates Revenue Growth Rate by Type (2012-2017)
Table Global Antibody-drug Conjugates Sales Volume (MT) and Market Share by Region (2012-2017)
Table Global Antibody-drug Conjugates Sales Share by Region (2012-2017)
Figure Sales Market Share of Antibody-drug Conjugates by Region (2012-2017)
Figure Global Antibody-drug Conjugates Sales Growth Rate by Region in 2016
Table Global Antibody-drug Conjugates Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Antibody-drug Conjugates Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Antibody-drug Conjugates by Region (2012-2017)
Figure Global Antibody-drug Conjugates Revenue Growth Rate by Region in 2016
Table Global Antibody-drug Conjugates Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Antibody-drug Conjugates Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Antibody-drug Conjugates by Region (2012-2017)
Figure Global Antibody-drug Conjugates Revenue Market Share by Region in 2016
Table Global Antibody-drug Conjugates Sales Volume (MT) and Market Share by Application (2012-2017)
Table Global Antibody-drug Conjugates Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Antibody-drug Conjugates by Application (2012-2017)
Figure Global Antibody-drug Conjugates Sales Market Share by Application (2012-2017)
Figure United States Antibody-drug Conjugates Sales (MT) and Growth Rate (2012-2017)
Figure United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Antibody-drug Conjugates Sales Price (USD/Kg) Trend (2012-2017)
Table United States Antibody-drug Conjugates Sales Volume (MT) by Players (2012-2017)
Table United States Antibody-drug Conjugates Sales Volume Market Share by Players (2012-2017)
Figure United States Antibody-drug Conjugates Sales Volume Market Share by Players in 2016
Table United States Antibody-drug Conjugates Sales Volume (MT) by Type (2012-2017)
Table United States Antibody-drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure United States Antibody-drug Conjugates Sales Volume Market Share by Type in 2016
Table United States Antibody-drug Conjugates Sales Volume (MT) by Application (2012-2017)
Table United States Antibody-drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure United States Antibody-drug Conjugates Sales Volume Market Share by Application in 2016
Figure China Antibody-drug Conjugates Sales (MT) and Growth Rate (2012-2017)
Figure China Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Antibody-drug Conjugates Sales Price (USD/Kg) Trend (2012-2017)
Table China Antibody-drug Conjugates Sales Volume (MT) by Players (2012-2017)
Table China Antibody-drug Conjugates Sales Volume Market Share by Players (2012-2017)
Figure China Antibody-drug Conjugates Sales Volume Market Share by Players in 2016
Table China Antibody-drug Conjugates Sales Volume (MT) by Type (2012-2017)
Table China Antibody-drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure China Antibody-drug Conjugates Sales Volume Market Share by Type in 2016
Table China Antibody-drug Conjugates Sales Volume (MT) by Application (2012-2017)
Table China Antibody-drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure China Antibody-drug Conjugates Sales Volume Market Share by Application in 2016
Figure Europe Antibody-drug Conjugates Sales (MT) and Growth Rate (2012-2017)
Figure Europe Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Antibody-drug Conjugates Sales Price (USD/Kg) Trend (2012-2017)
Table Europe Antibody-drug Conjugates Sales Volume (MT) by Players (2012-2017)
Table Europe Antibody-drug Conjugates Sales Volume Market Share by Players (2012-2017)
Figure Europe Antibody-drug Conjugates Sales Volume Market Share by Players in 2016
Table Europe Antibody-drug Conjugates Sales Volume (MT) by Type (2012-2017)
Table Europe Antibody-drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure Europe Antibody-drug Conjugates Sales Volume Market Share by Type in 2016
Table Europe Antibody-drug Conjugates Sales Volume (MT) by Application (2012-2017)
Table Europe Antibody-drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure Europe Antibody-drug Conjugates Sales Volume Market Share by Application in 2016
Figure Japan Antibody-drug Conjugates Sales (MT) and Growth Rate (2012-2017)
Figure Japan Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Antibody-drug Conjugates Sales Price (USD/Kg) Trend (2012-2017)
Table Japan Antibody-drug Conjugates Sales Volume (MT) by Players (2012-2017)
Table Japan Antibody-drug Conjugates Sales Volume Market Share by Players (2012-2017)
Figure Japan Antibody-drug Conjugates Sales Volume Market Share by Players in 2016
Table Japan Antibody-drug Conjugates Sales Volume (MT) by Type (2012-2017)
Table Japan Antibody-drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure Japan Antibody-drug Conjugates Sales Volume Market Share by Type in 2016
Table Japan Antibody-drug Conjugates Sales Volume (MT) by Application (2012-2017)
Table Japan Antibody-drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure Japan Antibody-drug Conjugates Sales Volume Market Share by Application in 2016
Figure Southeast Asia Antibody-drug Conjugates Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Antibody-drug Conjugates Sales Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia Antibody-drug Conjugates Sales Volume (MT) by Players (2012-2017)
Table Southeast Asia Antibody-drug Conjugates Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Antibody-drug Conjugates Sales Volume Market Share by Players in 2016
Table Southeast Asia Antibody-drug Conjugates Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia Antibody-drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Antibody-drug Conjugates Sales Volume Market Share by Type in 2016
Table Southeast Asia Antibody-drug Conjugates Sales Volume (MT) by Application (2012-2017)
Table Southeast Asia Antibody-drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Antibody-drug Conjugates Sales Volume Market Share by Application in 2016
Figure India Antibody-drug Conjugates Sales (MT) and Growth Rate (2012-2017)
Figure India Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Antibody-drug Conjugates Sales Price (USD/Kg) Trend (2012-2017)
Table India Antibody-drug Conjugates Sales Volume (MT) by Players (2012-2017)
Table India Antibody-drug Conjugates Sales Volume Market Share by Players (2012-2017)
Figure India Antibody-drug Conjugates Sales Volume Market Share by Players in 2016
Table India Antibody-drug Conjugates Sales Volume (MT) by Type (2012-2017)
Table India Antibody-drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure India Antibody-drug Conjugates Sales Volume Market Share by Type in 2016
Table India Antibody-drug Conjugates Sales Volume (MT) by Application (2012-2017)
Table India Antibody-drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure India Antibody-drug Conjugates Sales Volume Market Share by Application in 2016
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure F. Hoffmann-La Roche Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Seattle Genetics Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Seattle Genetics Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure Seattle Genetics Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Takeda Pharmaceuticals Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceuticals Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure Takeda Pharmaceuticals Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AbbVie Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure AbbVie Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure AbbVie Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table AbGenomics Basic Information List
Table AbGenomics Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AbGenomics Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure AbGenomics Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure AbGenomics Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table ADC Therapeutics Basic Information List
Table ADC Therapeutics Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ADC Therapeutics Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure ADC Therapeutics Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure ADC Therapeutics Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table Agensys Basic Information List
Table Agensys Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Agensys Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Agensys Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure Agensys Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table ALMAC Group Basic Information List
Table ALMAC Group Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ALMAC Group Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure ALMAC Group Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure ALMAC Group Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table Ambrx Basic Information List
Table Ambrx Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ambrx Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Ambrx Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure Ambrx Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Antibody-drug Conjugates Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Astellas Pharma Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Astellas Pharma Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure Astellas Pharma Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody-drug Conjugates
Figure Manufacturing Process Analysis of Antibody-drug Conjugates
Figure Antibody-drug Conjugates Industrial Chain Analysis
Table Raw Materials Sources of Antibody-drug Conjugates Major Players in 2016
Table Major Buyers of Antibody-drug Conjugates
Table Distributors/Traders List
Figure Global Antibody-drug Conjugates Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Global Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Antibody-drug Conjugates Price (USD/Kg) and Trend Forecast (2017-2022)
Table Global Antibody-drug Conjugates Sales Volume (MT) Forecast by Regions (2017-2022)
Figure Global Antibody-drug Conjugates Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Antibody-drug Conjugates Sales Volume Market Share Forecast by Regions in 2022
Table Global Antibody-drug Conjugates Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Antibody-drug Conjugates Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Antibody-drug Conjugates Revenue Market Share Forecast by Regions in 2022
Figure United States Antibody-drug Conjugates Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Antibody-drug Conjugates Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure China Antibody-drug Conjugates Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Antibody-drug Conjugates Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Europe Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Antibody-drug Conjugates Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Japan Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Antibody-drug Conjugates Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Antibody-drug Conjugates Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure India Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Antibody-drug Conjugates Sales (MT) Forecast by Type (2017-2022)
Figure Global Antibody-drug Conjugates Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Antibody-drug Conjugates Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Antibody-drug Conjugates Revenue Market Share Forecast by Type (2017-2022)
Table Global Antibody-drug Conjugates Price (USD/Kg) Forecast by Type (2017-2022)
Table Global Antibody-drug Conjugates Sales (MT) Forecast by Application (2017-2022)
Figure Global Antibody-drug Conjugates Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *